HEADER TRANSCRIPTION REGULATOR 07-JAN-11 3Q97 OBSLTE 30-AUG-17 3Q97 5T1Z TITLE CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH TITLE 2 GRIP PEPTIDE AND TWO ISOMERS OF ETHOXY TRIPHENYLETHYLENE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN RESIDUES 298-554; COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: LIGAND BINDING DOMAIN RESIDUES 298-554; COMPND 13 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 14 3 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: ESTROGEN RECEPTOR; COMPND 18 CHAIN: C, D; COMPND 19 FRAGMENT: LXXLL MOTIF 2 RESIDUES 686-698; COMPND 20 SYNONYM: NCOA-2, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75, BHLHE75, COMPND 21 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2, HTIF2; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ER ALPHA, ESR, ESR1, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ER ALPHA, ESR, ESR1, NR3A1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PMCSG7; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 OTHER_DETAILS: SYNTHETIC PEPTIDE KEYWDS TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR EXPDTA X-RAY DIFFRACTION AUTHOR S.S.RAJAN,Y.KIM,K.VANEK,A.JOACHIMIAK,C.JORDAN,G.L.GREENE REVDAT 2 30-AUG-17 3Q97 1 OBSLTE REVDAT 1 11-JAN-12 3Q97 0 JRNL AUTH S.S.RAJAN,Y.KIM,K.VANEK,A.JOACHIMIAK,C.JORDAN,G.L.GREENE JRNL TITL CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN JRNL TITL 2 COMPLEX WITH GRIP PEPTIDE AND TWO ISOMERS OF ETHOXY JRNL TITL 3 TRIPHENYLETHYLENE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 26836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1420 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2012 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4111 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.55000 REMARK 3 B22 (A**2) : 0.38000 REMARK 3 B33 (A**2) : -0.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.18000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.306 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.156 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.961 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4463 ; 0.010 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3032 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6043 ; 1.042 ; 2.014 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7376 ; 0.730 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 547 ; 4.540 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 186 ;37.599 ;23.871 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 836 ;14.624 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;17.811 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 690 ; 0.058 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4782 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 818 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2619 ; 1.169 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1046 ; 0.301 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4250 ; 2.060 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1844 ; 3.022 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1772 ; 4.548 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 301 A 549 REMARK 3 ORIGIN FOR THE GROUP (A): 14.4572 2.3337 5.8683 REMARK 3 T TENSOR REMARK 3 T11: 0.0356 T22: 0.0578 REMARK 3 T33: 0.0129 T12: -0.0137 REMARK 3 T13: -0.0044 T23: -0.0040 REMARK 3 L TENSOR REMARK 3 L11: 1.8530 L22: 1.1992 REMARK 3 L33: 0.9134 L12: -0.2994 REMARK 3 L13: -0.6238 L23: 0.0338 REMARK 3 S TENSOR REMARK 3 S11: 0.0141 S12: 0.0485 S13: 0.0718 REMARK 3 S21: -0.0259 S22: -0.0199 S23: -0.0597 REMARK 3 S31: -0.0333 S32: -0.0068 S33: 0.0058 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 304 B 548 REMARK 3 ORIGIN FOR THE GROUP (A): 6.5256 1.9527 29.8129 REMARK 3 T TENSOR REMARK 3 T11: 0.1056 T22: 0.0402 REMARK 3 T33: 0.0374 T12: 0.0069 REMARK 3 T13: 0.0314 T23: -0.0144 REMARK 3 L TENSOR REMARK 3 L11: 1.4632 L22: 1.6480 REMARK 3 L33: 2.6542 L12: 0.0146 REMARK 3 L13: 0.6479 L23: -0.3649 REMARK 3 S TENSOR REMARK 3 S11: -0.0625 S12: -0.0645 S13: -0.0658 REMARK 3 S21: 0.3167 S22: 0.0234 S23: -0.0122 REMARK 3 S31: -0.0230 S32: 0.1170 S33: 0.0391 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 687 C 696 REMARK 3 ORIGIN FOR THE GROUP (A): 25.4620 18.9844 1.8817 REMARK 3 T TENSOR REMARK 3 T11: 0.0505 T22: 0.1141 REMARK 3 T33: 0.2824 T12: -0.0165 REMARK 3 T13: 0.0428 T23: 0.1170 REMARK 3 L TENSOR REMARK 3 L11: 8.6900 L22: 26.1220 REMARK 3 L33: 10.3308 L12: -2.9830 REMARK 3 L13: -2.6923 L23: 0.3969 REMARK 3 S TENSOR REMARK 3 S11: 0.0482 S12: 0.8175 S13: 1.0122 REMARK 3 S21: -0.4377 S22: -0.3260 S23: -1.3110 REMARK 3 S31: -0.2757 S32: 0.3221 S33: 0.2778 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 686 D 698 REMARK 3 ORIGIN FOR THE GROUP (A): 10.6271 -15.7920 39.2218 REMARK 3 T TENSOR REMARK 3 T11: 0.4512 T22: 0.1525 REMARK 3 T33: 0.2251 T12: 0.0764 REMARK 3 T13: -0.0225 T23: 0.1015 REMARK 3 L TENSOR REMARK 3 L11: 29.5724 L22: 9.0187 REMARK 3 L33: 13.5307 L12: 0.9576 REMARK 3 L13: 4.2427 L23: -0.0914 REMARK 3 S TENSOR REMARK 3 S11: 0.1543 S12: -1.4091 S13: -2.4526 REMARK 3 S21: 0.1818 S22: 0.2341 S23: -0.5160 REMARK 3 S31: 1.6432 S32: -0.2093 S33: -0.3883 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3Q97 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063352. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28624 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.93600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.180 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1ZKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 M POTASSIUM BROMIDE, 30% W/V REMARK 280 POLYETHYLENE GLYCOL MME 2000, PH 8.3, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.10650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 295 REMARK 465 ASN A 296 REMARK 465 ALA A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 SER B 295 REMARK 465 ASN B 296 REMARK 465 ALA B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 686 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 398 77.35 -117.38 REMARK 500 VAL B 533 -70.54 -53.08 REMARK 500 HIS D 687 -4.44 -145.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Q97 A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SRR A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMT A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Q97 B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SRR B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q95 RELATED DB: PDB DBREF 3Q97 A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 3Q97 B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 3Q97 C 686 698 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 3Q97 D 686 698 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 3Q97 SER A 295 UNP P03372 EXPRESSION TAG SEQADV 3Q97 ASN A 296 UNP P03372 EXPRESSION TAG SEQADV 3Q97 ALA A 297 UNP P03372 EXPRESSION TAG SEQADV 3Q97 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 3Q97 SER B 295 UNP P03372 EXPRESSION TAG SEQADV 3Q97 ASN B 296 UNP P03372 EXPRESSION TAG SEQADV 3Q97 ALA B 297 UNP P03372 EXPRESSION TAG SEQADV 3Q97 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 260 SER ASN ALA ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 A 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 A 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 A 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 A 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 A 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 A 260 HIS ASP GLN VAL HIS LEU LEU GLU CME ALA TRP LEU GLU SEQRES 8 A 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 A 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 A 260 ARG ASN GLN GLY LYS CME VAL GLU GLY MET VAL GLU ILE SEQRES 11 A 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 A 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 A 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 A 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 A 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 A 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 A 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 A 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 A 260 LYS CME LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 A 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 260 SER ASN ALA ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 B 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 B 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 B 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 B 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 B 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 B 260 HIS ASP GLN VAL HIS LEU LEU GLU CME ALA TRP LEU GLU SEQRES 8 B 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 B 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 B 260 ARG ASN GLN GLY LYS CME VAL GLU GLY MET VAL GLU ILE SEQRES 11 B 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 B 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 B 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 B 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 B 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 B 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 B 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 B 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 B 260 LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 B 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 3Q97 CME A 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q97 CME A 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q97 CME A 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q97 CME B 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3Q97 CME B 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 381 17 HET CME A 417 20 HET CME A 530 10 HET CME B 381 10 HET CME B 417 10 HET Q97 A 600 27 HET SRR A 601 27 HET FMT A 1 3 HET GOL A 2 6 HET CL A 3 1 HET CL A 4 1 HET CL A 5 1 HET Q97 B 600 27 HET SRR B 601 27 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM Q97 4,4'-[(1Z)-1-(4-ETHOXYPHENYL)BUT-1-ENE-1,2- HETNAM 2 Q97 DIYL]DIPHENOL HETNAM SRR 4,4'-[2-(4-ETHOXYPHENYL)BUT-1-ENE-1,1-DIYL]DIPHENOL HETNAM FMT FORMIC ACID HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME 5(C5 H11 N O3 S2) FORMUL 5 Q97 2(C24 H24 O3) FORMUL 6 SRR 2(C24 H24 O3) FORMUL 7 FMT C H2 O2 FORMUL 8 GOL C3 H8 O3 FORMUL 9 CL 3(CL 1-) FORMUL 14 HOH *92(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 ALA A 322 1 12 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ARG A 412 LYS A 416 1 5 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLY A 457 PHE A 461 5 5 HELIX 10 10 LYS A 467 ALA A 493 1 27 HELIX 11 11 THR A 496 LYS A 531 1 36 HELIX 12 12 SER A 537 ALA A 546 1 10 HELIX 13 13 SER B 305 LEU B 310 5 6 HELIX 14 14 THR B 311 GLU B 323 1 13 HELIX 15 15 SER B 338 LYS B 362 1 25 HELIX 16 16 GLY B 366 LEU B 370 5 5 HELIX 17 17 THR B 371 MET B 396 1 26 HELIX 18 18 ASN B 413 VAL B 418 5 6 HELIX 19 19 GLY B 420 ASN B 439 1 20 HELIX 20 20 GLN B 441 SER B 456 1 16 HELIX 21 21 GLY B 457 PHE B 461 5 5 HELIX 22 22 SER B 468 ALA B 493 1 26 HELIX 23 23 THR B 496 ASN B 532 1 37 HELIX 24 24 SER B 537 ALA B 546 1 10 HELIX 25 25 LYS C 688 GLN C 695 1 8 HELIX 26 26 LYS D 688 SER D 697 1 10 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 LINK C GLU A 380 N CME A 381 1555 1555 1.33 LINK C CME A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N ACME A 417 1555 1555 1.33 LINK C LYS A 416 N BCME A 417 1555 1555 1.33 LINK C ACME A 417 N VAL A 418 1555 1555 1.33 LINK C BCME A 417 N VAL A 418 1555 1555 1.33 LINK C LYS A 529 N CME A 530 1555 1555 1.33 LINK C CME A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CME B 381 1555 1555 1.33 LINK C CME B 381 N ALA B 382 1555 1555 1.33 LINK C LYS B 416 N CME B 417 1555 1555 1.33 LINK C CME B 417 N VAL B 418 1555 1555 1.33 SITE 1 AC1 11 MET A 343 THR A 347 GLU A 353 TRP A 383 SITE 2 AC1 11 ARG A 394 PHE A 404 PHE A 425 LEU A 428 SITE 3 AC1 11 GLY A 521 HIS A 524 LEU A 525 SITE 1 AC2 16 HOH A 7 THR A 347 ALA A 350 GLU A 353 SITE 2 AC2 16 LEU A 387 ARG A 394 PHE A 404 GLU A 419 SITE 3 AC2 16 GLY A 420 MET A 421 ILE A 424 LEU A 428 SITE 4 AC2 16 HIS A 524 LEU A 525 MET A 528 LEU A 540 SITE 1 AC3 6 SER A 512 GLU B 385 ASN B 455 SER B 456 SITE 2 AC3 6 LEU B 511 ARG B 515 SITE 1 AC4 11 HOH A 90 HIS A 476 LEU A 479 ASP A 480 SITE 2 AC4 11 THR A 483 HOH B 47 HOH B 54 ARG B 434 SITE 3 AC4 11 ALA B 505 GLN B 506 LEU B 509 SITE 1 AC5 2 VAL A 422 GLU A 423 SITE 1 AC6 3 ASP A 332 ARG A 335 PRO A 336 SITE 1 AC7 4 HOH A 13 ARG A 352 HOH A 555 ARG B 352 SITE 1 AC8 10 MET B 343 THR B 347 GLU B 353 MET B 388 SITE 2 AC8 10 ARG B 394 PHE B 404 GLY B 521 HIS B 524 SITE 3 AC8 10 LEU B 525 LEU B 536 SITE 1 AC9 12 HOH B 17 THR B 347 ALA B 350 GLU B 353 SITE 2 AC9 12 LEU B 387 ARG B 394 MET B 421 ILE B 424 SITE 3 AC9 12 LEU B 428 HIS B 524 LEU B 525 MET B 528 CRYST1 56.091 84.213 58.967 90.00 108.28 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017828 0.000000 0.005889 0.00000 SCALE2 0.000000 0.011875 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017860 0.00000